Status:
WITHDRAWN
Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study
Lead Sponsor:
University Medical Center Groningen
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Rationale: The investigators hypothesize that genetics and the nasal epithelial response to SARS-CoV2 are critical determinants of the immune response to viral infection, and predict clinical outcome...
Detailed Description
Rationale: The currently ongoing world-crippling pandemic with the new SARS-CoV2 virus shows the desperate and urgent need for a better understanding of the biological pathways activated by the virus...
Eligibility Criteria
Inclusion
- Patients have to be tested (PCR) positive for SARS-CoV2 infection.
- Provided written informed consent
Exclusion
- 1\. No comprehension of Dutch or English language
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04359459
Start Date
November 1 2022
End Date
November 1 2022
Last Update
November 4 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.